Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2024-10-16 00:00:00 ET · period of report 2024-10-14 · accession 0001773751-24-000321 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-16 | 2024-10-14 | HIMS | Okupe Oluyemi | CFO | S - Sale+OE | $20.31 | -269.7K | 162.2K | -62% | -$5.48M |
| DM | 2024-10-16 | 2024-10-14 | HIMS | Okupe Oluyemi | CFO | M - OptEx | $5.36 | +219.5K | 207.7K | New | +$1.18M |
| DM | 2024-10-16 | 2024-10-14 | HIMS | Okupe Oluyemi | CFO | M - OptEx | $0.00 | -219.5K | 91.8K | -71% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-10-14 | S | D | 6,326 | $19.95 | 397,595 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-10-14 | M | A | 207,814 | $5.01 | 415,502 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-10-14 | S | D | 2,388 | $20.00 | 413,114 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Class A Common Stock | 2024-10-14 | S | D | 9,193 | $19.95 | 403,921 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.82 - $20.015 The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Class A Common Stock | 2024-10-14 | S | D | 11,700 | $20.04 | 345,763 | D | — | — | (F5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.02 - $20.045. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Common | Class A Common Stock | 2024-10-14 | S | D | 16,400 | $21.07 | 145,763 | D | — | — | (F7) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.00 - $21.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Class A Common Stock | 2024-10-14 | S | D | 40,132 | $19.98 | 357,463 | D | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.95 - $20.02. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Common | Class A Common Stock | 2024-10-14 | S | D | 183,600 | $20.37 | 162,163 | D | — | — | (F6) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.045 - $20.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9 | Common | Class A Common Stock | 2024-10-14 | M | A | 11,700 | $11.53 | 207,688 | D | — | — | |
| 10 | Derivative | Stock Option (right to buy) | 2024-10-14 | M | D | 207,814 | $0.00 | 620,033 | D | $5.01 · — to 2032-02-23 | 207,814 Class A Common Stock | (F9) 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. |
| 11 | Derivative | Stock Option (right to buy) | 2024-10-14 | M | D | 11,700 | $0.00 | 91,832 | D | $11.53 · — to 2033-03-01 | 11,700 Class A Common Stock | (F8) The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. |